Postprandial gastrokinetic agent
AssigneesZeria Pharmaceutical Co., Ltd., Saitama University
InventorsTakafumi SAKAI, Ichiro SAKATA, Kayuri KURODA, Makoto YOSHIMURA
Life of this patent
Estimating the term…
Abstract
To provide a therapeutic agent for gastrointestinal disorder such as diabetic gastroparesis. A postprandial gastrokinetic agent containing (A) ghrelin or a ghrelin agonist and (B) motilin or a motilin agonist as active ingredients, in which both the ingredients (A) and (B) are administered so as to act on the stomach after food intake.
Claims9
A postprandial gastrokinetic agent comprising (A) ghrelin or a ghrelin agonist and (B) motilin or a motilin agonist as active ingredients, wherein both the ingredients (A) and (B) are adapted to be administered to a subject in need thereof so as to act on the stomach of the subject after food intake.
A method for enhancing postprandial gastric motility, comprising administering both (A) ghrelin or a ghrelin agonist and (B) motilin or a motilin agonist to a subject in need thereof so as to act on the stomach of the subject after food intake.
7-12. (canceled)
Dependencies are inferred from the claim text.